InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by GRAHAM RICHARD A, SVP, Développement. Director active across 1 companies, notably Theravance Biopharma, Inc.. Cumulatively, 10 filings have been published. The latest transaction was filed on 20 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
€32,6093,947 shares@ €8.26170.0039% mcap6.1% of flow
Ordinary Shares
SEC:0001415889-22-005629:0·
€172,28120,377 shares@ €8.45470.021% mcap32.4% of flow
Ordinary Shares
SEC:0001415889-22-001697:0·
0240,000 shares0
Ordinary Shares
SEC:0001179110-21-010636·
0240,000 shares0
Ordinary Shares
SEC:0001179110-21-010636:0·
€31,3494,263 shares@ €7.35370.0037% mcap19.2% of flow
Ordinary Shares
SEC:0001415889-21-005468·
€31,3494,263 shares@ €7.35370.0037% mcap5.9% of flow
Ordinary Shares
SEC:0001415889-21-005468:0·
€82,0506,819 shares@ €12.03260.0098% mcap50.3% of flow
Ordinary Shares
SEC:0001179110-21-008392·
€82,0506,819 shares@ €12.03260.0098% mcap15.5% of flow
Ordinary Shares
SEC:0001179110-21-008392:0·
€49,6493,410 shares@ €14.55990.0059% mcap30.5% of flow
Ordinary Shares
SEC:0001179110-21-005840·
€49,6493,410 shares@ €14.55990.0059% mcap9.4% of flow
Ordinary Shares
SEC:0001179110-21-005840:0·
10 of 10 declarations
About GRAHAM RICHARD A
Richard A. Graham is Senior Vice President, Development at Theravance Biopharma, Inc., a biopharmaceutical company focused on innovation. In his role, he oversees product development and research initiatives, ensuring the company remains at the forefront of medical advancements. His expertise in strategic development is essential to Theravance's mission.
